Raze Therapeutics
Latest round
- Series A
Last raised
- Oct 2014
Total raised
- $24M
Investors
- 5
About Raze Therapeutics
Raze Therapeutics specializes in developing cancer therapies that target metabolic dependencies of tumors. Founded in Cambridge, US, the company has not undergone significant pivots and operates independently.Raze Therapeutics focuses on the design and development of novel therapeutics aimed at metabolic pathways in cancer cells. Their primary products involve targeted therapies designed to exploit metabolic vulnerabilities in tumors, which can enhance the efficacy of existing treatments and improve patient outcomes.The revenue model for Raze Therapeutics is centered around partnerships and collaborations with pharmaceutical companies for developing their therapeutics. Revenue is generated through milestone payments and potential royalties on product sales once their therapies reach the market.Raze Therapeutics plans to expand its product offerings by developing new therapeutics targeting additional metabolic pathways by the end of 2025.80 mn will be utilized to accelerate research and development initiatives and support clinical trials for their lead candidates. The company is also exploring market expansion opportunities in Europe and Asia, aiming to establish partnerships with local healthcare providers and research institutions by 2026.
Who invested in Raze Therapeutics
5 investors across 2 rounds
See all investors in Raze Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Raze Therapeutics
Who invested in Raze Therapeutics?
Raze Therapeutics has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Raze Therapeutics raised?
Raze Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Raze Therapeutics last raise money?
Raze Therapeutics's most recent round on record is a Series A, in Oct 2014.
What does Raze Therapeutics do?
Raze Therapeutics specializes in developing cancer therapies that target metabolic dependencies of tumors.
Where is Raze Therapeutics headquartered?
Raze Therapeutics is headquartered in Cambridge, US.
Which VCs invest in companies like Raze Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Raze Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Raze Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.